We need a new paradigm for addiction that puts psychology first and recognizes its heterogeneity. Only then will we see that ...

Recently, GLP-1s like Ozempic and Mounjaro have gained attention for weight loss benefits, leading to increased use among individuals seeking to shed pounds. With GLP-1s’ rising popularity, questions ...

The blockbuster injections that began life as humble diabetes medications have rapidly evolved into one of modern medicine’s most surprising success stories. First they reshaped weight-loss treatment, ...

Last April, neuroscientist Sue Grigson received an e-mail from a man detailing his years-long struggle to kick addiction — first to opioids, and then to the very medication meant to help him quit. The ...

From a clinical standpoint, GLP-1s are not considered addictive in the traditional sense. Ozempic, Mounjaro, and other GLP-1s do not act on the brain’s reward pathways in the same way addictive ...